{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:48:54Z","timestamp":1793882934683,"version":"4.7.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives:<\/jats:title>\n                  <jats:p>Recent studies have shown that complement hyperactivation contributes to development of thrombotic microangiopathy. The evaluation of complement biomarkers is known to be influenced by inappropriate specimen handling. However, there has been no study fully addressing this topic.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>Blood from each donor was subjected to 62 different handling conditions prior to complement assays.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Complement biomarkers (C4d\/C3a\/factor Bb\/C5a\/C5b-9) are stable at room temperature (RT) for up to 4 hours in whole blood containing citrate or EDTA. However, under similar conditions, levels of C4d and C3a were significantly higher in serum than those in plasma. Thawing of the samples on ice or at RT had no significant effect on complement levels. In contrast, thawing at 37\u00b0C resulted in striking increases in levels of the complement system in serum and citrated plasma but not in EDTA plasma. Up to four freeze\/thaw cycles on ice or RT did not substantially increase the levels of C3a, factor Bb, C5a, and C5b-9 but had a significant effect on C4d. Long-term storage of citrated plasma at \u221280\u00b0C for up to 6 years had no significant effect on levels of complement factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>The results from this study thus provide crucial guidelines for future investigations using complement biomarkers to define the role of complement system in disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1309\/ajcpxpd7zqxntial","type":"journal-article","created":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T20:51:19Z","timestamp":1426539079000},"page":"558-565","source":"Crossref","is-referenced-by-count":99,"title":["Effect of Blood Sampling, Processing, and Storage on the Measurement of Complement Activation Biomarkers"],"prefix":"10.1093","volume":"143","author":[{"given":"Shangbin","family":"Yang","sequence":"first","affiliation":[{"name":"1Department of Pathology and Internal Medicine, College of Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McGookey","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Internal Medicine, College of Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"2Translational Medicine, Alexion Corporation, Cheshire, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spero R.","family":"Cataland","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Internal Medicine, College of Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng M.","family":"Wu","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Internal Medicine, College of Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,4,1]]},"reference":[{"key":"2023012005132669500_b1-1430558","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2007.10.793","article-title":"Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia","volume":"198","author":"Lynch","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2023012005132669500_b2-1430558","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","article-title":"Alternative complement pathway assessment in patients with atypical HUS","volume":"365","author":"Roumenina","year":"2011","journal-title":"J Immunol Methods"},{"key":"2023012005132669500_b3-1430558","doi-asserted-by":"crossref","first-page":"J276","DOI":"10.1016\/j.jaut.2009.11.014","article-title":"The complement system in systemic autoimmune disease","volume":"34","author":"Chen","year":"2010","journal-title":"J Autoimmun"},{"key":"2023012005132669500_b4-1430558","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"2023012005132669500_b5-1430558","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/jnci\/djt205","article-title":"Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer","volume":"105","author":"Ajona","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"2023012005132669500_b6-1430558","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5482\/HAMO-12-12-0025","article-title":"Complement activation in thrombotic microangiopathy","volume":"33","author":"Karpman","year":"2013","journal-title":"Hamostaseologie"},{"key":"2023012005132669500_b7-1430558","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"2023012005132669500_b8-1430558","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/asheducation-2011.1.15","article-title":"Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations","volume":"2011","author":"Kavanagh","year":"2011","journal-title":"Hematology"},{"key":"2023012005132669500_b9-1430558","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2165\/11208300-000000000-00000","article-title":"Eculizumab: a review of its use in paroxysmal nocturnal haemoglobinuria","volume":"71","author":"McKeage","year":"2011","journal-title":"Drugs"},{"key":"2023012005132669500_b10-1430558","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"key":"2023012005132669500_b11-1430558","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1538-7836.2012.04674.x","article-title":"Complement activation in thrombotic thrombocytopenic purpura","volume":"10","author":"Reti","year":"2012","journal-title":"J Thrombosis Haemost"},{"key":"2023012005132669500_b12-1430558","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/bjh.12707","article-title":"Complement and cytokine response in acute thrombotic thrombocytopenic purpura","volume":"164","author":"Westwood","year":"2014","journal-title":"Br J Haematol"},{"key":"2023012005132669500_b13-1430558","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/jth.12369","article-title":"Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura","volume":"11","author":"Wu","year":"2013","journal-title":"J Thromb Haemost"},{"key":"2023012005132669500_b14-1430558","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2141.2012.09084.x","article-title":"Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura","volume":"157","author":"Chapin","year":"2012","journal-title":"Br J Haematol"},{"key":"2023012005132669500_b15-1430558","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant\u2013associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"2023012005132669500_b16-1430558","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J Exp Med"},{"key":"2023012005132669500_b17-1430558","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","article-title":"Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome","volume":"24","author":"Ariceta","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"2023012005132669500_b18-1430558","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023012005132669500_b19-1430558","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.2008.07571.x","article-title":"Relationship between HLA-DP supertype and survival in childhood acute lymphoblastic leukaemia: evidence for selective loss of immunological control of residual disease?","volume":"145","author":"Taylor","year":"2009","journal-title":"Br J Haematol"},{"key":"2023012005132669500_b20-1430558","doi-asserted-by":"crossref","first-page":"962702","DOI":"10.1155\/2012\/962702","article-title":"Complement diagnostics: concepts, indications, and practical guidelines","volume":"2012","author":"Nilsson","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"2023012005132669500_b21-1430558","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","article-title":"Biomarkers of the alternative pathway and terminal complement activity at presentation confirms the clinical diagnosis of aHUS and differentiates aHUS from TTP","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"key":"2023012005132669500_b22-1430558","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/ard.51.7.892","article-title":"Effects of coagulation temperature on measurements of complement function in serum samples from patients with systemic lupus erythematosus","volume":"51","author":"Baatrup","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"2023012005132669500_b23-1430558","first-page":"484","article-title":"Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation","volume":"73","author":"Mollnes","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"2023012005132669500_b24-1430558","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/clinchem\/22.2.267","article-title":"Complement C3 in serum and plasma, as measured by radial immunodiffusion with four commercial kits","volume":"22","author":"Vladutiu","year":"1976","journal-title":"Clin Chem"},{"key":"2023012005132669500_b25-1430558","doi-asserted-by":"crossref","first-page":"e59372","DOI":"10.1371\/journal.pone.0059372","article-title":"Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"},{"key":"2023012005132669500_b26-1430558","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.1301221","article-title":"Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy","volume":"191","author":"Tati","year":"2013","journal-title":"J Immunol"},{"issue":"pt 1","key":"2023012005132669500_b27-1430558","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/clinchem\/45.8.1190","article-title":"Possible mechanism for in vitro complement activation in blood and plasma samples: futhan\/EDTA controls in vitro complement activation","volume":"45","author":"Pfeifer","year":"1999","journal-title":"Clin Chem"},{"key":"2023012005132669500_b28-1430558","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0022-1759(82)90083-7","article-title":"Influence of time, temperature and coagulation on the measurement of C3, C3 split products and C4","volume":"55","author":"Sinosich","year":"1982","journal-title":"J Immunol Methods"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/143\/4\/558\/48792646\/ajcp_143_4_558.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/143\/4\/558\/48792646\/ajcp_143_4_558.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T05:16:15Z","timestamp":1674191775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/143\/4\/558\/1761371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,1]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,1]]},"published-print":{"date-parts":[[2015,4,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpxpd7zqxntial","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,4,1]]},"published":{"date-parts":[[2015,4,1]]}}}